Gland Pharma Ltd reports that the ANSM issued a final report on June 03, 2025, citing 11 observations from an inspection at Cenexi's Facility conducted between December 9-19, 2024; the facility will continue operations without disruption as they implement a corrective plan over the next 3-12 months.